Literature DB >> 21538130

Pediatric low-grade glioma survivors experience high quality of life.

Lindy Musial-Bright1, Louisa Panteli, Pablo Hernáiz Driever.   

Abstract

PURPOSE: The purpose of this study was to determine pediatric low-grade glioma survivors' quality of life and late morbidity including motor, sensory, and cognitive deficits.
METHODS: We surveyed 49 survivors and their parents (KINDL questionnaire).
RESULTS: Despite tumor and treatment-associated morbidity, survivors (25 boys and 24 girls, median age at diagnosis 7.8 years), but not their parents, rated their total quality of life higher than their peers. Although all survivors had some late morbidity, half of them were able to conduct their daily lives without restriction.
CONCLUSION: These results reflect survivors' effective coping mechanisms and underscore the difficulties of assessing quality of life in pediatric populations.

Entities:  

Mesh:

Year:  2011        PMID: 21538130     DOI: 10.1007/s00381-011-1467-0

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  63 in total

1.  The challenge of response shift for quality-of-life-based clinical oncology research.

Authors:  M A Sprangers; C E Schwartz
Journal:  Ann Oncol       Date:  1999-07       Impact factor: 32.976

2.  Cerebral vascular accidents in patients over the age of 60. II. Prognosis.

Authors:  J RANKIN
Journal:  Scott Med J       Date:  1957-05       Impact factor: 0.729

3.  Population-based epidemiologic data on brain tumors in German children.

Authors:  P Kaatsch; C H Rickert; J Kühl; J Schüz; J Michaelis
Journal:  Cancer       Date:  2001-12-15       Impact factor: 6.860

4.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

5.  Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study.

Authors:  M Klein; J J Heimans; N K Aaronson; H M van der Ploeg; J Grit; M Muller; T J Postma; J J Mooij; R H Boerman; G N Beute; G J Ossenkoppele; G W van Imhoff; A W Dekker; J Jolles; B J Slotman; H Struikmans; M J B Taphoorn
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

6.  Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).

Authors:  A K Gnekow; R-D Kortmann; T Pietsch; A Emser
Journal:  Klin Padiatr       Date:  2004 Nov-Dec       Impact factor: 1.349

Review 7.  Intracranial gliomas in neurofibromatosis type 1.

Authors:  R Listernick; J Charrow; D H Gutmann
Journal:  Am J Med Genet       Date:  1999-03-26

8.  Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group.

Authors:  G M Kiebert; D Curran; N K Aaronson; M Bolla; J Menten; E H Rutten; E Nordman; M E Silvestre; M Pierart; A B Karim
Journal:  Eur J Cancer       Date:  1998-11       Impact factor: 9.162

9.  Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy.

Authors:  C A North; R B North; J A Epstein; S Piantadosi; M D Wharam
Journal:  Cancer       Date:  1990-07-01       Impact factor: 6.860

10.  Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Melissa M Hudson; Ann C Mertens; Yutaka Yasui; Wendy Hobbie; Hegang Chen; James G Gurney; Mark Yeazel; Christopher J Recklitis; Neyssa Marina; Leslie R Robison; Kevin C Oeffinger
Journal:  JAMA       Date:  2003-09-24       Impact factor: 157.335

View more
  6 in total

1.  Life satisfaction in adult survivors of childhood brain tumors.

Authors:  Deborah B Crom; Zhenghong Li; Tara M Brinkman; Melissa M Hudson; Gregory T Armstrong; Joseph Neglia; Kirsten K Ness
Journal:  J Pediatr Oncol Nurs       Date:  2014-07-15       Impact factor: 1.636

2.  Child-related characteristics predicting subsequent health-related quality of life in 8- to 14-year-old children with and without cerebellar tumors: a prospective longitudinal study.

Authors:  Kim S Bull; Christina Liossi; David Culliford; Janet L Peacock; Colin R Kennedy
Journal:  Neurooncol Pract       Date:  2014-08-11

3.  Morphological brain lesions of pediatric cerebellar tumor survivors correlate with inferior neurocognitive function but do not affect health-related quality of life.

Authors:  Rajiv Kumar Khajuria; Friederike Blankenburg; Ines Wuithschick; Stefan Rueckriegel; Ulrich-Wilhelm Thomale; Michael Mansour; Pablo Hernáiz Driever
Journal:  Childs Nerv Syst       Date:  2015-02-17       Impact factor: 1.475

4.  Prospective longitudinal evaluation of emotional and behavioral functioning in pediatric patients with low-grade glioma treated with conformal radiation therapy.

Authors:  Victoria W Willard; Heather M Conklin; Shengjie Wu; Thomas E Merchant
Journal:  J Neurooncol       Date:  2015-01-09       Impact factor: 4.130

5.  Are pediatric brain tumors on the rise in the USA? Significant incidence and survival findings from the SEER database analysis.

Authors:  Swetal Patel; Amit Bhatnagar; Christopher Wear; Stephen Osiro; Abigail Gabriel; David Kimball; Alana John; Paul J Fields; R Shane Tubbs; Marios Loukas
Journal:  Childs Nerv Syst       Date:  2013-10-27       Impact factor: 1.475

Review 6.  Pediatric low-grade gliomas: next biologically driven steps.

Authors:  David T W Jones; Mark W Kieran; Eric Bouffet; Sanda Alexandrescu; Pratiti Bandopadhayay; Miriam Bornhorst; David Ellison; Jason Fangusaro; Michael J Fisher; Nicholas Foreman; Maryam Fouladi; Darren Hargrave; Cynthia Hawkins; Nada Jabado; Maura Massimino; Sabine Mueller; Giorgio Perilongo; Antoinette Y N Schouten van Meeteren; Uri Tabori; Katherine Warren; Angela J Waanders; David Walker; William Weiss; Olaf Witt; Karen Wright; Yuan Zhu; Daniel C Bowers; Stefan M Pfister; Roger J Packer
Journal:  Neuro Oncol       Date:  2018-01-22       Impact factor: 12.300

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.